Top

Current Cardiology Reports

Published in:

01-12-2017 | Stroke (JF Meschia, Section Editor)

Clinical Management of Cavernous Malformations

Author: Kelly D. Flemming

Published in: Current Cardiology Reports | Issue 12/2017

Abstract

Purpose of Review

This study aims to review the current epidemiology and clinical management of patients with cavernous malformations (CM).

Recent Findings

Hemorrhage is the most feared complication and leads to morbidity in patients with CM. Multiple studies including three meta-analyses have provided useful estimates of hemorrhage risk, but have failed to identify a modifiable risk factor for prevention of cavernous malformation related hemorrhage. In treating the CM itself, surgical risk is weighed against the natural history. However, accumulating knowledge regarding the roles of CCM 1, 2, and 3 genes has led to the discovery of potential therapeutic targets.

Summary

The risk of future hemorrhage in patients with CM is highest in those who have had previously clinical hemorrhages. Estimated risks are helpful in counseling patients and comparing to the risk of surgery. Future clinical trials of candidate medications are likely to target those patients with prior clinical hemorrhage in whom the surgical risk is deemed high.

Clatterbuck R, Eberhart C, Crain B, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry. 2001;71(2):188–92.PubMedPubMedCentralCrossRef

•• Akers A, Salman RA-S, Awad I, Dahlem K, Flemming K, Hart B, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery. 2017;80(5):665–80. This guideline highlights recommendations for the clinical management of patients with cavernous malformations based on existing data. PubMedCrossRef

Brinjikji W, El-Masri A, Wald J, Flemming K, Lanzino G. Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age. Child Nerv Syst. 2017;

Ciricillo S, Dillon W, Fink M, Edwards M. Progression of multiple cryptic vascular malformations associated with anomalous venous drainage: case report. J Neurosurg. 1994;81(3):477–81.PubMedCrossRef

Maeder P, Gudinchet F, Meuli R, Tribolet ND. Development of a cavernous malformation of the brain. AJNR Am J Neuroradiol. 1998;19(6):1141–3.PubMed

Perrini P, Lanzion G. The association of venous developmental anomalies and cavernous malformations:pathophysiological, diagnostic, and surgical considerations. Neurosurg Focus. 2006;21(1):e5.PubMedCrossRef

Dammann P, Wrede KH, Maderwald S, El Hindy N, Mueller O, Chen B, et al. The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI. J Neurol Neurosurg Psychiatry. 2013;84(2):194–200.PubMedCrossRef

Cutsforth-Gregory JK, Lanzino G, Link MJ, Brown RD Jr, Flemming KD. Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort. J Neurosurg. 2015;122(5):1214–22.PubMedCrossRef

Detwiler P, Porter R, Zabramski J, Spetzler R. De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage: case report and review of the literature. J Neurosurg. 1997;87(4):629–32.PubMedCrossRef

10.

Maraire J, Awad I. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995;37(4):591–605.PubMedCrossRef

11.

Ogilvy C, Moayeri N, Golden J. Appearance of a cavernous hemangioma in the cerebral cortex after a biopsy of a deeper lesion. Neurosurgery. 1993;33(2):307–9.PubMedCrossRef

12.

Mindea S, Yang B, Shenkar R, Bendok B, Batjer H, Awad I. Cerebral cavernous malformations: clinical insights from genetic studies. Neurosurg Focus. 2006;21(1):e1.PubMedCrossRef

13.

Revencu N, Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet. 2006;43(9):716–21.PubMedPubMedCentralCrossRef

14.

• Retta S, Glading A. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: two sides of the same coin. Int J Biochem Cell Biol. 2016;81:254–70. This article highlights the proposed theories in the pathogenesis of cavernous malformations including potential sites for pharmacologic intervention PubMedPubMedCentralCrossRef

15.

Dammann P, Wrede K, Zhu Y, Matsushige T, Maderwald S, Umutlu L, et al. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI. J Neurosurg. 2017;126(2):570–7.PubMedCrossRef

16.

Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34(5):1163–9.PubMedCrossRef

17.

Brown RD, Wiebers DO, Torner JC, O’Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965-1992. Neurology. 1996;46:949–52.PubMedCrossRef

18.

Berry R, Alpers B, White J. The site, structure and frequency of intracranial aneurysms, angiomas and arteriovenous abnormalities. In: C M, editor. Research publications: association for research in nervous and mental disease. Baltimore: Williams and Wilkins; 1966. p. 4–72.

19.

Otten P, Pizzolato G, Rilliet B, Berney J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie. 1989;35(2):128–31.

20.

Del Curling OJ, Kelly DL, Elster A, Craven T. An analysis of the natural history of cavernous angiomas. J Neurosurg. 1991;75(5):702–8.PubMedCrossRef

21.

Sage M, Brophy B, Sweeney C, Phipps S, Perrerr L, Sandhu A, et al. Cavernous haemangiomas (angiomas) of the brain: clinically significant lesions. Australas Radiol. 1993;37:147–55.PubMedCrossRef

22.

Bos D, Poels MM, Adams HH, Akoudad S, Cremers LG, Zonneveld HI, et al. Prevalence, clinical management, and natural course of incidental findings on brain MR images: the population-based Rotterdam Scan Study. Radiology. 2016;281(2):507–15.PubMedCrossRef

23.

Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, et al. Incidental findings on brain MRI in the general population. NEJM. 2007;357(18):1821–8.PubMedCrossRef

24.

Zoe M, Whiteley WN, Longstreth W Jr, Weber F, Lee YC, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.CrossRef

25.

Flemming K, Graff-Radford J, Aakre J, Lanzino G, Brown RD Jr, Mielke M, et al. Population-based prevalence of cerebral cavernous malformations in older adults: Mayo clinic study of aging. JAMA Neurol. 2017;74(7):801–5.PubMedCrossRef

26.

Flemming KD, Brown RD, Link MJ. Seasonal variation in hemorrhage and focal neurologic deficit due to intracerebral cavernous malformations. J Clin Neurosci. 2015;22(6):969–71.PubMedCrossRef

27.

Flemming K, Link M, Christianson T, Brown RD Jr. The prospective hemorrhage risk of intracerebral cavernous malformations. Neurology. 2012;78(9):632–6.PubMedCrossRef

28.

Moriarity J, Clatterbuck R, Rigamonti D. The natural history of cavernous malformations. Neurosurg Clin N Am. 1999;10(3):411–7.PubMed

29.

Aboian MS, Daniels DJ, Rammos SK, Pozzati E, Lanzino G. The putative role of the venous system in the genesis of vascular malformations. Neurosurg Focus. 2009;27(5):E9.PubMedCrossRef

30.

• Morrison L, Akers A. Cerebral cavernous malformation, familial. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors GeneReviews® [Internet] Seattle (WA): University of Washington, Seattle; 1993-2017 2003 Feb 24 [updated 2016 Aug 4]. 2016. This article highlights the clinical differences seen in the familial form of cavernous malformations compared to the sporadic form and reviews current understanding of the genetics and available testing.

31.

Jellinger K. Vascular malformations of the central nervous system: a morphological overview. Neurosurg Rev. 1986;9(3):177–216.PubMedCrossRef

32.

McCormick W. Pathology of vascular malformations of the brain. In: Wilson C, Stein B, editors. Intracranial Arteriovenous malformations. Baltimore: Williams and Wilkins; 1984. p. 44–63.

33.

Rigamonti D, Drayer B, Johnson P, Hadley M, Zabramski J, Spetzler R. The MRI appearance of cavernous malformations (angiomas). J Neurosurg. 1987;67(4):518–24.PubMedCrossRef

34.

Rigamonti D, Hadley M, Drayer B, Johnson P, Hoenig-Rigamonti K, Knight J, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med. 1988;319(6):343–7.PubMedCrossRef

35.

Requena I, Arias M, Lopez-Ibor L, Pereiro I, Barba A, Alonso A, et al. Cavernomas of the central nervous system: clinical and neuroimaging manifestations in 47 patients. J Neurol Neurosurg Psychiatry. 1991;54(7):590–4.PubMedPubMedCentralCrossRef

36.

Robinson J, Awad I, Little J. Natural history of the cavernous angioma. J Neurosurg. 1991;75(5):709–14.PubMedCrossRef

37.

Rosenow F, Alonso-Vanegas MA, Baumgartner C, Blümcke I, Carreño M, Gizewski ER, et al. Cavernoma-related epilepsy: review and recommendations for mangement—report of the Surgical Task Force of the ILAE Commission on therapeutic strategies. Epilepsia. 2013;54(12):2025–35.PubMedCrossRef

38.

Al-Shahi Salman R, Berg M, Morrison L, Awad I, Board AASA. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke. 2008;39(12):3129–30.CrossRef

39.

Al-Shahi Salman R, Hall JM, Horne MA, Moultrie F, Josephson CB, Bhattacharya JJ, et al. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol. 2012;11(3):217–24.PubMedCrossRef

40.

Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG, et al. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015;17(3):188–96.PubMedCrossRef

41.

Flemming K, Lanzino G. Management of unruptured intracranial aneurysms and cerebrovascular malformations. Continuum (Minneap Minn). 2017;23(1, Cerebrovascular Disease):181–210. https://doi.org/10.1212/CON.0000000000000418.

42.

Lobato R, Perez C, Rivas J, Cordobes F. Clinical, radiological, and pathological spectrum of angiographically occult intracranialvascular malformations. Analysis of 21 cases and review of the literature. J Neurosurg. 1988;68(4):518–31.PubMedCrossRef

43.

Zabramski J, Wascher T, Spetzler R, Johnson B, Golfinos J, Drayer B, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80(3):422–32.PubMedCrossRef

44.

Sparacia G, Speciale C, Banco A, Bencivinni F, Midiri M. Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form. Neuroradiol J. 2016;29(5):326–35.PubMedPubMedCentralCrossRef

45.

Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg. 1995;83(1):56–9.PubMedCrossRef

46.

Giombini S, Morello G. Cavernous angiomas of the brain. Account of fourteen personal cases and review of the literature. Acta Neurochir. 1978;40(1–2):61–82.PubMedCrossRef

47.

Kim D, Park Y, Choi J, Chung S, Lee K. An analysis of the natural history of cavernous malformations. Surg Neurol. 1997;48(1):9–18.PubMedCrossRef

48.

Kondziolka D, Lunsford L, Kestle J. The natural history of cerebral cavernous malformations. J Neurosurg. 1995;83(5):820–4.PubMedCrossRef

49.

Kupersmith M, Kalish H, Epstein F, Yu G, Berenstein A, Woo H, et al. Natural history of brainstem cavernous malformations. Neurosurgery. 2001;48(1):47–54.PubMed

50.

Pasqualin A, Vivenza C, Rosta L, Scienza R, Pien RD, Colangeli M. Spontaneous regression of intracranial arteriovenous malformation. Surg Neurol. 1993;39:385–91.CrossRef

51.

Porter P, Willinsky R, Harper W, Wallace M. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg. 1997;87(2):190–7.PubMedCrossRef

52.

Voigt K, Yasargil M. Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case. Neurochirurgia (Stuttg). 1976;19(2):59–68.

53.

Barker F, Amin-Hanjani S, Butler W, Lyons S, Ojemann R, Chapman P, et al. Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. Neurosurgery. 2001;49(1):15–25.PubMed

54.

Duffau H, Capelle L, Sichez J, Faillot T, Bitar A, Arthuis F, et al. Early radiologically proven rebleeding from intracranial cavernous angiomas: report of 6 cases and review of the literature. Acta Neurochir. 1997;139(10):914–22.PubMedCrossRef

55.

Gross B, Du R. Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis. J Neurosurg. 2017;126(4):1079–87.PubMedCrossRef

56.

•• Horne MA, Flemming K, Su I-C, Stapf C, Jeon JP, Li D, et al. Clinical course of untreated cerebral cavernous malformations: an individual patient data meta-analysis. Lancet Neurol. 2015;15:166–73. This study is an individual patient data meta-analysis providing estimates of bleeding risks in patients with prior hemorrhage and brainstem location compared to those in other locations. PubMedCrossRef

57.

Taslimi S, Modabbernia A, Amin-Hanjani S, Barker F, Macdonald R. Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies. Neurology. 2016;86(21):1984–91.PubMedPubMedCentralCrossRef

58.

Cantu C, Murillo-Bonilla L, Arauz A, Higuera J, Padilla J, Barinagarrementeria F. Predictive factors for intracerebral hemorrhage in patients with cavernous angiomas. Neurol Res. 2005;27(3):314–8.PubMedCrossRef

59.

Abdulrauf S, Kaynar M, Awad I. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999;44(1):41–7.PubMedCrossRef

60.

Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R, et al. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 2011;76(18):1548–54.

61.

Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006;21(1):e7.PubMedCrossRef

62.

Awad I, Robinson J. Cavernous malformation and epilepsy. In: Awad I, Barrow D, editors. Cavernous Malfromations. Park Ridge: AANS; 1993. p. 49–63.

63.

Labauge P, Bouly S, Parker F, Gallas S, Emery E, Loiseau H, et al. Outcome in 53 patients with spinal cord cavernomas. Surg Neurol. 2008;70:176–81.PubMedCrossRef

64.

Kalani MY, Zabramski JM. Risk for symptomatic hemorrhage of cerebral cavernous malformations during pregnancy. J Neurosurg. 2013;118(1):50–5.PubMedCrossRef

65.

Witiw CD, Abou-Hamden A, Kulkarni AV, Silvaggio JA, Schneider C, Wallace MC. Cerebral cavernous malformations and pregnancy: hemorrhage risk and influence on obstetrical management. Neurosurgery. 2012;71(3):626–30. discussion 31PubMedCrossRef

66.

Flemming K, Link M, Christianson T, Brown R Jr. Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg. 2013;118(1):43–6.PubMedCrossRef

67.

Schneble H, Soumare A, Herve D, Bresson D, Guichard J, Riant F, et al. Antithrombotic therapy and bleeding risk in a prospective cohort of patients with cerebral cavernous malformation. Stroke. 2012;43(3):3196–9.PubMedCrossRef

68.

McCracken D, Willie J, Fernald B, Saindane A, Drane D, Barrow D, et al. Magnetic resonance thermometry-guided stereotactic laser ablation of cavernous malformations in drug-resistant epilepsy: imaging and clinical results. Oper Neurosurg. 2016;12(1):39–48.CrossRef

69.

Acerbi F, Corte EL, D'Incerti L, Ferroli P. Are there effective alternatives to surgery for the treatment of symptomatic brainstem cavernous malformation? World Neurosurg. 2015;83(3):313–6.PubMedCrossRef

70.

Awad I. Unfolding knowledge on cerebral cavernous malformations. Surg Neurol. 2005;63(4):317–8.PubMedCrossRef

71.

Bravia L, Rudinia N, Cuttanoa R, Giampietroa C, Maddalunoa L, Ferrarinia L, et al. Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. PNAS. 2015;112(27):8421–6.CrossRef

72.

Gibson C, Whitehead K, Li D. The role of vitamin D in endothelial cells with CCM2. [Abstract Presented at the Angioma Alliance ]. In press 2013.

73.

Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation. 2015;131(3):289–99.PubMedCrossRef

74.

McDonald DA, Shi C, Shenkar R, Stockton RA, Liu F, Ginsberg MH, et al. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012;43(2):571–4.PubMedCrossRef

75.

Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010;207(4):881–96.PubMedPubMedCentralCrossRef

76.

Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N, et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017;545(7654):305–10.

77.

Mikati A, Khanna O, Zhang L, Girard R, Shenkar R, Guo X, et al. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015;35(10):1632–9.PubMedPubMedCentralCrossRef

78.

Mikati A, Tan H, Shenkar R, Li L, Zhang L, Guo X, et al. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014;45(2).

79.

Mikati AG, Tan H, Shenkar R, Li L, Zhang L, Guo X, et al. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014;45(2):598–601.PubMedCrossRef

Title: Clinical Management of Cavernous Malformations
Author: Kelly D. Flemming
Publication date: 01-12-2017
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 12/2017
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-017-0931-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinical Management of Cavernous Malformations

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 12/2017

The Genetics of Physical Activity

Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns?

Training and Service Provision in Cardiovascular CT: International Challenges and Solutions

Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead

Echocardiography in Infective Endocarditis: State of the Art

Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page